| Literature DB >> 29233282 |
Samuel K Peasah1, Leisa L Marshall2.
Abstract
BACKGROUND ANDEntities:
Keywords: Active learning; Debate; Healthcare
Mesh:
Year: 2017 PMID: 29233282 PMCID: PMC7102848 DOI: 10.1016/j.cptl.2017.01.012
Source DB: PubMed Journal: Curr Pharm Teach Learn ISSN: 1877-1297
Topics for the debates in 2014 and 2015.
| Drug prices are highest in the US, should the government set prices like in some developed countries? | Would the Affordable Care Act eventually lead to an efficient healthcare system? | |
| A patient was declared brain dead in California after a tonsillectomy; the family wants to keep her alive but a Judge ruled against them based on California law. A pregnant mother is brain dead and the husband wants her feeding tube removed but Texas law forbids termination of the baby. Should technology be allowed to sustain life? | Would the US Healthcare system be better if structured similar to the Education system? | |
| Should a patients’ right to their medication (for example Plan-B) trump a pharmacist's religious or cultural rights? | Gilead is selling its’ hepatitis C drug, Solvadi® for $1000 a pill. Should the FDA be allowed to put a cap on drug prices during drug approval? | |
| Would you recommend long term care insurance? | Three states have enacted “Death with Dignity” laws. Would you advocate for such a law in your state? | |
| New York Mayor wanted to control the size of soda sold in restaurants as a means to control obesity, should the government regulate health behaviors? | Is medical malpractice litigation necessary? | |
| Managed care is a better system than traditional insurance | With the growing threats of epidemics such as Ebola and SARS, should the government use travel restrictions as a public safety tool? | |
| Should the US government adopt comparative effectiveness analysis as a cost containment tool? | Chronic diseases are arguably the biggest drivers of healthcare cost. Should the government enact laws to legislate health behavior? | |
| The generic market in India is about $11 billion due to the laxity of patency laws. A recent ruling by the Indian Supreme Court denied Novartis’ plea to patent an updated version of their cancer drug, Glivec®. Should there be laxness in patency laws in developing countries? | Should professional bodies like the state pharmacy boards become involved in personal behaviors like domestic violence? | |
| Corporatization of pharmacy has had negative impact on pharmacy practice | Does Advocacy and lobbying, “the third house”, reduce the efficiency of government? | |
| Should the US adopt a single-payer healthcare delivery system? | ACCP is advocating residencies as an entry level requirement for practicing pharmacists. Would you support such a requirement? | |
| Should healthcare be a right or a commodity in the US? | Given the recent problems with compounding (meningitis outbreak) would it be better for pharmacy practice to focus only on clinical pharmacy and leave compounding to the industry? |
US = United States; ACCP = American College of Clinical Pharmacy; SARS = Severe Acute Respiratory Syndrome; FDA = Federal Drug Administration.
Characteristics of enrolled students in 2014 (175a; response rate 97%) and 2015 (151a, response rate 99%).
| Categories | 2014 | 2015 | |
|---|---|---|---|
| Respondents # (%) | Respondents # (%) | ||
| =<25 | 107 (62) | 100 (67) | |
| 26–30 | 46 (27) | 36 (24) | |
| 31–40 | 14 (8) | 11 (7) | |
| >40 | 5 (3) | 3 (2) | |
| White (non-Hispanic) | 96 (55) | 59 (39) | |
| Black (non-Hispanic) | 31 (18) | 34 (22) | |
| Hispanic | 4 (2) | 5 (3) | |
| Asian | 37 (21) | 53 (35) | |
| other | 7 (4) | 1 (1) | |
| Male | 68 (40) | 61 (41) | |
| Female | 102 (60) | 89 (59) | |
| Doctorate | 15 (8) | 25 (16) | |
| Masters | 9 (5) | 5 (3) | |
| Bachelors | 103 (58) | 90 (58) | |
| Other | 50 (28) | 34 (22) | |
| Liberal | 34 (20) | 26 (17) | |
| Conservative | 59 (34) | 39 (39) | |
| Moderate | 40 (23) | 48 (31) | |
| Libertarian | 11 (6) | 8 (5) | |
| Don't Know | 30 (17) | 36 (23) | |
# of students.
Number and percentages of responders to pre-and post-debate surveys per debate topic in 2014.
| Pre-Debate | Post-Debate | Changed Mind | |||||
|---|---|---|---|---|---|---|---|
| # (%) RR | # (%) RR | # (%) RR | |||||
| Yes | No | Don't Know | Yes | No | Yes | No | |
| 56 | 80 | 16 | 58 | 98 | 38 | 118 | |
| (36) | (53) | (11) | (37) | (63) | (24) | (76) | |
| 87 | 16 | 11 | 114 | 22 | 33 | 103 | |
| (76) | (14) | (10) | (84) | (16) | (24) | (76) | |
| 91 | 42 | – | 75 | 56 | 27 | 104 | |
| (68) | (32) | – | (57) | (43) | (21) | (79) | |
| 96 | 10 | 11 | 130 | 36 | 42 | 124 | |
| (82) | (9) | (9) | (78) | (22) | (25) | (75) | |
| 29 | 69 | 13 | 60 | 108 | 40 | 128 | |
| (26) | (62) | (12) | (36) | (64) | (24) | (76) | |
| 58 | 21 | 57 | 65 | 64 | 69 | 55 | |
| (43) | (15) | (42) | (50) | (50) | (53) | (43) | |
| 71 | 19 | 43 | 60 | 81 | 76 | 65 | |
| (53) | (14) | (32) | (43) | (57) | (54) | (46) | |
| 36 | 57 | 28 | 55 | 79 | 49 | 79 | |
| (30) | (47) | (23) | (41) | (63) | (37) | (59) | |
| 82 | 28 | 33 | 89 | 52 | 43 | 98 | |
| (57) | (20) | (23) | (63) | (37) | (30) | (70) | |
| 36 | 59 | 44 | 36 | 91 | 57 | 70 | |
| (26) | (42) | (32) | (28) | (72) | (45) | (55) | |
| 59 | 66 | 14 | 44 | 64 | 29 | 79 | |
| (42) | (47) | (10) | (41) | (59) | (27) | (73) | |
| 52 | 41 | 30 | 54 | 66 | 34 | 86 | |
| (42) | (33) | (24) | (45) | (55) | (28) | (72) | |
| 37 | 35 | 51 | 41 | 79 | 43 | 77 | |
| (30) | (28) | (41) | (34) | (66) | (36) | (64) | |
| 30 | 39 | 54 | 43 | 77 | 40 | 80 | |
| (24) | (32) | (44) | (36) | (64) | (33) | (67) | |
| 35 | 42 | 46 | 49 | 71 | 40 | 80 | |
| (28) | (34) | (37) | (41) | (59) | (33) | (67) | |
UK = United Kingdom.
# is number of respondents and RR=response rate.
Number and percentages of responders to pre-and post-debate surveys per debate topic in 2015.
| Pre-Debate | Post-Debate | Changed Mind | |||||
|---|---|---|---|---|---|---|---|
| # (%) RR | # (%) RR | # (%) RR | |||||
| Yes | No | Don’t Know | Yes | No | Yes | No | |
| 52 | 45 | 28 | 68 | 74 | 26 | 115 | |
| (41) | (35) | (22) | (48) | (52) | (18) | (81) | |
| 97 | 8 | 21 | 112 | 23 | 36 | 100 | |
| (77) | (6) | (17) | (81) | (17) | (26) | (72) | |
| 92 | 29 | 5 | 98 | 34 | 27 | 105 | |
| (73) | (23) | (4) | (74) | (26) | (21) | (80) | |
| 63 | 39 | 31 | 78 | 52 | 30 | 99 | |
| (47) | (29) | (23) | (60) | (40) | (23) | (76) | |
| 20 | 70 | 54 | 29 | 109 | 45 | 90 | |
| (14) | (49) | (38) | (21) | (79) | (33) | (65) | |
| 86 | 30 | 18 | 67 | 56 | 29 | 91 | |
| (64) | (22) | (13) | (54) | (46) | (24) | (74) | |
| 52 | 72 | 17 | 64 | 58 | 43 | 80 | |
| (37) | (51) | (12) | (52) | (47) | (35) | (65) | |
| 45 | 52 | 21 | 41 | 63 | 33 | 70 | |
| (38) | (44) | (18) | (39) | (60) | (31) | (67) | |
| 21 | 103 | 6 | 27 | 104 | 19 | 111 | |
| (16) | (79) | (4) | (21) | (79) | (15) | (85) | |
| 36 | 78 | 20 | 43 | 84 | 39 | 89 | |
| (27) | (58) | (15) | (34) | (66) | (30) | (70) | |
| 34 | 80 | 16 | 35 | 83 | 29 | 88 | |
| (26) | (62) | (12) | (30) | (70) | (25) | (75) | |
| 67 | 26 | 43 | 106 | 27 | 52 | 80 | |
| (49) | (19) | (32) | (80) | (20) | (39) | (60) | |
| 60 | 22 | 51 | 88 | 44 | 45 | 84 | |
| (44) | (16) | (38) | (66) | (33) | (34) | (63) | |
| 61 | 35 | 39 | 81 | 49 | 40 | 91 | |
| (45) | (26) | (29) | (61) | (37) | (30) | (68) | |
RR=response rate.
Fig. 12015 Student survey responses on the usefulness of debates pre and post-course.